246 related articles for article (PubMed ID: 8381887)
21. Therapeutic intervention in disseminated intravascular coagulation: have we made any progress in the last millennium?
Levi M; de Jonge E; van der Poll T
Blood Rev; 2002 Dec; 16 Suppl 1():S29-34. PubMed ID: 12918785
[TBL] [Abstract][Full Text] [Related]
22. Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis.
Dhainaut JF; Yan SB; Cariou A; Mira JP
Crit Care Med; 2002 May; 30(5 Suppl):S318-24. PubMed ID: 12004254
[TBL] [Abstract][Full Text] [Related]
23. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
24. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
25. Thrombomodulin, an endothelial anticoagulant; its structure, function and expression.
Maruyama I
Jpn Circ J; 1992 Feb; 56(2):187-91. PubMed ID: 1312651
[TBL] [Abstract][Full Text] [Related]
26. [Protein C, protein S and thrombomodulin: one of the natural antithrombotic mechanisms].
Lobato-Mendizábal E; Ruiz-Argüelles GJ
Rev Invest Clin; 1990; 42(1):54-62. PubMed ID: 2173090
[TBL] [Abstract][Full Text] [Related]
27. Thrombomodulin.
Esmon NL
Prog Hemost Thromb; 1989; 9():29-55. PubMed ID: 2536481
[No Abstract] [Full Text] [Related]
28. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Nawa K; Itani T; Ono M; Sakano K; Marumoto Y; Iwamoto M
Thromb Haemost; 1992 Mar; 67(3):366-70. PubMed ID: 1322570
[TBL] [Abstract][Full Text] [Related]
29. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
[TBL] [Abstract][Full Text] [Related]
30. Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation.
Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kuroda T; Sakata Y
Thromb Res; 2013 May; 131(5):436-43. PubMed ID: 23566534
[TBL] [Abstract][Full Text] [Related]
31. [Haemostaseological aspects of perioperative blood management].
Scherer RU
Zentralbl Chir; 2003 Jun; 128(6):473-80. PubMed ID: 12865952
[TBL] [Abstract][Full Text] [Related]
32. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
Wu KK; Matijevic-Aleksic N
Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
[TBL] [Abstract][Full Text] [Related]
33. [Principles of the therapy for disseminated intravascular coagulation: current status and new trends].
Takahashi H
Nihon Rinsho; 1993 Jan; 51(1):79-86. PubMed ID: 7679452
[TBL] [Abstract][Full Text] [Related]
34. [The thrombomodulin-protein C anticoagulant system (current status of the problem and clinical outlook)].
Smirnov MD; Zherdeva LV
Ter Arkh; 1988; 60(5):131-6. PubMed ID: 2845592
[No Abstract] [Full Text] [Related]
35. Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis.
Endo S; Inada K; Nakae H; Takakuwa T; Kasai T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M
Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):277-88. PubMed ID: 8747795
[TBL] [Abstract][Full Text] [Related]
36. The diagnosis and management of disseminated intravascular coagulation.
Taylor FB; Kinasewitz GT
Curr Hematol Rep; 2002 Sep; 1(1):34-40. PubMed ID: 12901123
[TBL] [Abstract][Full Text] [Related]
37. Use of recombinant human soluble thrombomodulin in the management of HELLP syndrome complicated by DIC.
Ikezoe T; Ikenoue N; Uchikawa N; Kojima S; Fukaya T; Yokoyama A
Thromb Res; 2010 Sep; 126(3):e238-40. PubMed ID: 20627281
[No Abstract] [Full Text] [Related]
38. Overview of the postulated mechanisms linking cancer and thrombosis.
ten Cate H; Falanga A
Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
[TBL] [Abstract][Full Text] [Related]
39. [Disseminated intravascular coagulation syndrome and protein C].
Kvasnicka J; Ehler Z; Polívková J; Krska Z; Hájek Z; Malíková I; Horák P
Sb Lek; 2002; 103(2):257-64. PubMed ID: 12688150
[TBL] [Abstract][Full Text] [Related]
40. [Anticoagulant and fibrinolytic systems of the injured vascular endothelial cells].
Takeya H; Suzuki K
Rinsho Byori; 1994 Apr; 42(4):333-9. PubMed ID: 8176840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
